Two-center collaborative evaluation of performance of the BD phoenix automated microbiology system for identification and antimicrobial susceptibility testing of gram-negative bacteria

Journal of Clinical Microbiology

Volumn 44, Issue 11, 2006, Pages 4085-4094

  Menozzi, Maria Grazia ^a   Eigner, Ulrich ^b   Covan, Silvia ^a   Rossi, Sabina ^a   Somenzi, Pietro ^a   Dettori, Giuseppe ^a   Chezzi, Carlo ^a   Fahr, Anne Marie ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b Laboratory Group   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHEM DERIVATIVE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; FOLIC ACID ANTAGONIST; GATIFLOXACIN; GENTAMICIN; KANAMYCIN; LEVOFLOXACIN; LOMEFLOXACIN; MONOBACTAM DERIVATIVE; MOXIFLOXACIN; NALIDIXIC ACID; NETILMICIN; NORFLOXACIN; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TICARCILLIN; TOBRAMYCIN; UNINDEXED DRUG;

ANALYTICAL ERROR; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOMATION; BACTERIAL STRAIN; ENTEROBACTERIACEAE; ESCHERICHIA COLI; EVALUATION; GRAM NEGATIVE BACTERIUM; INTERMETHOD COMPARISON; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; LABORATORY; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AUTOMATION; BACTERIAL TYPING TECHNIQUES; BACTERIOLOGICAL TECHNIQUES; ENTEROBACTERIACEAE; GRAM-NEGATIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; REPRODUCIBILITY OF RESULTS;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA;

EID: 33750957516     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00614-06     Document Type: Article

References (31)

1. Brenner, D. J., P. A. D. Grimont, A. G. Steigerwalt, G. R. Fanning, E. Ageron, and C. F. Riddle. 1993. Classification of citrobacteria by DNA hybridization: designation of Citrobacter farmeri sp. nov., Citrobacter youngae sp. nov., Citrobacter braakii sp. nov., Citrobacter werkmanii sp. nov., Citrobacter sedlakii sp. nov., and three unnamed Citrobacter genomospecies. Int. J. Syst. Bacteriol. 43:645-658.
2. Brenner, D. J., C. M. O'Hara, P. A. D. Grimont, J. M. Janda, E. Falsen, E. Aldova, E. Ageron, J. Shindler, S. L. Abbott, and A. G. Steigerwalt. 1999. Biochemical identification of Citrobacter species defined by DNA hybridization and description of Citrobacter gillenii sp. nov. (formerly Citrobacter genomospecies 10) and Citrobacter murliniae sp. nov. (formerly Citrobacter genomospecies 11). J. Clin. Microbiol. 37:2619-2624.
3. Brisse, S., S. Stefani, J. Verhoef, A. Van Belkum, P. Vandamme, and W. Goessens. 2002. Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex. J. Clin. Microbiol. 40:1743-1748.
4. Cantón, R., E. Loza, M. Del Carmen Conejo, F. Baquero, L. Martinez, and the Mensura Collaborative Group. 2003. Quality control for β-lactam susceptibility testing with a well-defined collection of Enterobacteriaceae and Pseudomonas aeruginosa strains in Spain. J. Clin. Microbiol. 41:1912-1918.
5. Center for Devices and Radiological Health. 2000. Guidance on review criteria for assessment of antimicrobial susceptibility devices. U.S. Department of Health and Human Services, U.S. Food and Drug Administration, Washington, D.C.
6. Chapin, K. C., and M. C. Musgnug. 2003. Validation of the automated reading and incubation system with Sensititre plates for antimicrobial susceptibility testing. J. Clin. Microbiol. 41:1951-1956.
7. Doern, G. V., A. B. Brueggemann, R. Perla, J. Daly, D. Halkias, R. N. Jones, and M. A. Saubolle. 1997. Multicenter laboratory evaluation of the bio-Mérieux Vitek antimicrobial susceptibility testing system with II antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa. J. Clin. Microbiol. 35:2115-2119.
8. Donay, J.-L., D. Mathieu, P. Fernandes, C. Prégermain, P. Bruel, A. Wargnier, I. Casin, F. X. Weill, P. H. Lagrange, and J. L. Hermann. 2004. Evaluation of the automated Phoenix system for potential routine use in the clinical microbiology laboratory. J. Clin. Microbiol. 42:1542-1546.
9. Eigner, U., A. Schmid, U. Wild, D. Bertsch, and A.-M. Fahr. 2005. Analysis of the comparative workflow and performance characteristics of the VITEK 2 and Phoenix systems. J. Clin. Microbiol. 43:3829-3834.
10. Endimiani, A., F. Luzzaro, A. Tamborini, G. Lombardi, V. Elia, R. Belloni, and A. Toniolo. 2002. Identification and antimicrobial susceptibility testing of clinical isolates of non-fermenting gram-negative bacteria by the Phoenix automated microbiology system. New Microbiol. 25:323-329.
11. Fahr, A.-M., U. Eigner, M. Armbrust, A. Caganic, G. Dettori, C. Chezzi, L. Bertoncini, M. Benecchi, and M. G. Menozzi. 2003. Two-center collaborative evaluation of the performance of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of Enterococcus spp. and Staphylococcus spp. J. Clin. Microbiol. 41:1135-1142.
12. Freney, J., C. Herve, M. Desmonceaux, F. Allard, J. M. Boeufgras, D. Monget, and J. Fleurette. 1991. Description and evaluation of the semiautomated 4-hour ATB 32E method for identification of members of the family Enterobacteriaceae. J. Clin. Microbiol. 29:138-141.
13. Funke, G., and P. Funke-Kissling. 2004. Use of the BD PHOENIX automated microbiology system for direct identification and susceptibility testing of gram-negative rods from positive blood cultures in a three-phase trial. J. Clin. Microbiol. 42:1466-1470.
14. Giakkoupi, P., L. S. Tzouvelekis, G. L. Daikos, V. Miriagou, G. Petrikkos, N. J. Legakis, and A. C. Vatopoulos. 2005. Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates. J. Clin. Microbiol. 43:494-496.
15. Hoffmann, H., and A. Roggenkamp. 2003. Population genetics of the nomenspecies Enterobacter cloacae. Appl. Environ. Microbiol. 69:5306-5318.
16. Jones, R. N., S. A. Marshall, and L. Zerva. 1997. Critical evaluation of the Vitek GNS F6 card results compared to standardized, reference susceptibility test methods. Diagn. Microbiol. Infect. Dis. 128:35-40.
17. Joyanes, P., M. Del Carmen Conejo, L. Martinez-Martinez, and E. J. Perea. 2001. Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples. J. Clin. Microbiol. 39:3247-3253.
18. Karlowsky, J. A., M. K. Weaver, C. Thornsberry, M. J. Dowzicky, M. E. Jones, and D. F. Sahm. 2003. Comparison of four antimicrobial susceptibility testing methods to determine the in vitro activities of piperacillin and piperacillin-tazobactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa. J. Clin. Microbiol. 41:3339-3343.
19. Leverstein-van Hall, M. A., A. C. Fluit, A. Paauw, A. T. A. Box, S. Brisse, and J. Verhoef. 2002. Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 automated instruments for detection of extended-spectrum beta-lactamases in multiresistant Escherichia coli and Klebsiella spp. J. Clin. Microbiol. 40:3703-3711.
20. Linscott, A. J., and W. J. Brown. 2005. Evaluation of four commercially available extended-spectrum beta-lactamase phenotypic confirmation tests. J. Clin. Microbiol. 43:1081-1085.
21. Livermore, D. M., T. G. Winstanley, and K. P. Shannon. 2001. Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J. Antimicrob. Chemother. 48(Suppl. S1):87-102.
22. Marco, F., A. Jurado, and M. T. Jimenez de Anta. 2004. Evaluación del sistema Phoenix para identificación y determinación de la sensibilidad de aislamientos clínicos. Estudio comparativo con el sistema Microscan. Rev. Esp. Quimoterap. 17:169-176.
23. National Committee for Clinical Laboratory Standards. 1999. Performance standards for antimicrobial susceptibility testing: ninth informational supplement, vol. 19, no. 1. NCCLS document M100-S9. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
24. Pagani, L., E. Dell'Amico, R. Migliavacca, M. M. D'Andrea, E. Giacobone, G. Amicosante, E. Romero, and G. M. Rossolini. 2003. Multiple CTX-M-type extended-spectrum β-lactamases in nosocomial isolates of Enterobacteriaceae from a hospital in northern Italy. J. Clin. Microbiol. 41:4264-4269.
25. Pitout, J. D. D., D. B. Gregson, L. Poirel, J.-A. McClure, P. Le, and D. L. Church. 2005. Detection of Pseudomonas aeruginosa producing metallo-β-lactamases in a large centralized laboratory. J. Clin. Microbiol. 43:3129-3135.
26. Potz, N. A. C., M. Colman, M. Warner, R. Reynolds, and D. M. Livermore. 2004. False-positive extended-spectrum β-lactamase test for Klebsiella oxytoca strains hyperproducing K1 β-lactamase. J. Antimicrob. Chemother. 53:545-547.
27. Sanguinetti, M., B. Posteraro, T. Spanu, D. Ciccaglione, L. Romano, B. Fiori, G. Nicoletti, S. Zanetti, and G. Fadda. 2003. Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum β-lactamase detection method. J. Clin. Microbiol. 41:1463-1468.
28. Stefaniuk, E., A. Baraniak, M. Gniadkowski, and W. Hryniewicz. 2003. Evaluation of the BD Phoenix automated identification and susceptibility testing system in clinical microbiology laboratory practice. Eur. J. Clin. Microbiol. Infect. Dis. 22:479-485.
29. Steward, C. D., J. M. Mohammed, J. M. Swenson, S. A. Stocker, P. P. Williams, R. P. Gaynes, J. E. McGowan, Jr., and F. C. Tenover. 2003. Antimicrobial susceptibility testing of carbapenems: multicenter validity testing and accuracy levels of five antimicrobial test methods for detecting resistance in Enterobacteriaceae and Pseudomonas aeruginosa isolates. J. Clin. Microbiol. 41:351-358.
30. Steward, C. D., S. A. Stocker, J. M. Swenson, C. M. O'Hara, J. R. Edwards, R. P. Gaynes, J. E. McGowan, Jr., and F. C. Tenover. 1999. Comparison of agar dilution, disk diffusion, MicroScan, and Vitek antimicrobial susceptibility testing methods to broth microdilution for detection of fluoroquinolone-resistant isolates of the family Enterobacteriaceae. J. Clin. Microbiol. 37:544-547.
31. Stüremburg, E., I. Sobottka, H.-H. Feucht, D. Mack, and R. Laufs. 2003. Comparison of BDPhoenix and Vitek2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates. Diagn. Microbiol. Infect. Dis. 45:29-34.